Japan, Oct. 30 -- TAKEDA PHARMACEUTICAL CO LTD has got intellectual property rights for 'MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIa.' Other related details are as follows:
Application Number: JP,2023-117873
Category (FI): C12N5/10,C12N15/63@Z,C12N15/13,C12N1/19,C12N1/21,A61K39/395@N,A61P11/00,A61P27/02,A61P7/02,A61P9/00,C07K16/36,C12P21/08
Stage: Grant (IP right document published.)
Filing Date: July 19, 2023
Publication Date: Oct. 11, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
